Tiverton Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.73M Hold
42,532
0.06% 224
2019
Q2
$1.83M Buy
42,532
+16,180
+61% +$622K 0.07% 208
2019
Q1
$1.01M Hold
26,352
0.04% 241
2018
Q4
$931K Buy
26,352
+6,650
+34% +$241K 0.06% 187
2018
Q3
$758K Buy
19,702
+45
+0.2% +$1.57K 0.04% 216
2018
Q2
$643K Sell
19,657
-512
-3% -$15.4K 0.03% 222
2018
Q1
$551K Buy
20,169
+414
+2% +$11.3K 0.04% 205
2017
Q4
$490K Buy
+19,755
New +$545K 0.03% 241

Other funds holding BSX

Tiverton Asset Management's BSX Position: Q3 2019 in Review

Tiverton Asset Management held its Boston Scientific (BSX) position steady in Q3 2019 at 42,532 shares worth $1.73M. The position accounts for 0.06% of the portfolio, ranked #224.

Tiverton Asset Management first reported a position in BSX in Q4 2017 and has held it in 8 quarters since. The position peaked at $1.83M in Q2 2019. 770 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Tiverton Asset Management held 42,532 shares of Boston Scientific worth $1.73M as of Q3 2019.
  • Tiverton Asset Management left its Boston Scientific share count unchanged in Q3 2019.
  • Boston Scientific made up 0.06% of Tiverton Asset Management's portfolio in Q3 2019, its #224 holding.
  • Tiverton Asset Management first reported a position in Boston Scientific in Q4 2017 and has held it in 8 quarters since.
  • Tiverton Asset Management's Boston Scientific position peaked at $1.83M in Q2 2019.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.